AI assistant
Sending…
Genmab — Director's Dealing 2017
Apr 4, 2017
3365_rpt_2017-04-04_0f6217f0-b502-4ff8-9160-c8cb9b17193f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Jan van de Winkel | |||
| 2. | Reason for the notification | ||||
| a) | Position/status | President & Chief Executive Officer | |||
| b) | Initial notifica tion/Amendment |
Initial notification | |||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | |||
| a) | Name | Genmab A/S | |||
| b) | LEI | 529900MTJPDPE4MHJ122 | |||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instru ment |
Share | |||
| Identification code | DK0010272202 | ||||
| b) | Nature of the transaction | Subscription of shares (exercise of warrants) | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| DKK 80.55 | 10,000 | ||||
| DKK 174 | 20,000 | ||||
| DKK 225.90 | 2,500 | ||||
| DKK 272 | 50,000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
82,500 shares | ||||
| - Price |
DKK 223.64 | ||||
| e) | Date of the transaction | 2017-04-04 | |||
| f) | Place of the transaction | Outside a market place |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||||
|---|---|---|---|---|---|---|
| a) | Name | David A. Eatwell | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Executive Vice President & Chief Financial Officer | ||||
| b) | Initial notifica tion/Amendment |
Initial notification | ||||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | ||||
| a) | Name | Genmab A/S | ||||
| b) | LEI | 529900MTJPDPE4MHJ122 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) | Description of the financial instrument, type of instru ment |
Share | ||||
| Identification code | DK0010272202 | |||||
| b) | Nature of the transaction | Subscription of shares (exercise of warrants) | ||||
| c) | Price(s) and volume(s) | Price(s) DKK 246 |
Volume(s) 40,000 |
|||
| d) | Aggregated information - Aggregated volume - Price |
|||||
| e) | Date of the transaction | 2017-04-04 | ||||
| f) | Place of the transaction | Outside a market place |
More from Genmab
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Foreign Filer Report
2026
May 7
Foreign Filer Report
2026
Apr 17
Foreign Filer Report
2026
Apr 17
Share Issue/Capital Change
2026
Apr 17
Share Issue/Capital Change
2026
Apr 17
Foreign Filer Report
2026
Apr 14
Major Shareholding Notification
2026
Apr 14